$Long Term Combination Treatment With Bevacizumab, Pegylated Liposomal Doxorubicin and Regional Abdominal Hyperthermia in Platinum Refractory Ovarian Cancer: A Case Report and Review of the Literature$
QR Code

Long Term Combination Treatment With Bevacizumab, Pegylated Liposomal Doxorubicin and Regional Abdominal Hyperthermia in Platinum Refractory Ovarian Cancer: A Case Report and Review of the Literature

Platinum resistance constitutes a therapeutic challenge in the treatment of ovarian cancer, with overall unsatisfactory response rates to standard chemotherapy and correspondingly low survival. Regional abdominal hyperthermia and bevacizumab are treatment options that have both shown the capacity to...

Full description

Saved in:

Bibliographic Details
Published in:	Anticancer research Vol. 31; no. 8; pp. 2675 - 2677
Main Authors:	PIETZNER, Klaus, BIANCA SCHMUCK, Rosa, FOTOPOULOU, Christina, GELLERMANN, Johanna, ISMAEEL, Fakher, HEE CHO, Chie, KALDEN, Michael, SEHOULI, Jalid
Format:	Conference Proceeding Journal Article
Language:	English
Published:	Attiki International Institute of Anticancer Research 01-08-2011
Subjects:	Abdomen Adult Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab Biological and medical sciences Doxorubicin - administration & dosage Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Hyperthermia, Induced Medical sciences Ovarian Neoplasms - drug therapy Ovarian Neoplasms - therapy Tumors Antineoplastic agent Ovary cancer Monoclonal antibody Regional Doxorubicin Bevacizumab Isomerases Cancerology Platinum platinum-refractory Antiangiogenic agent Pegylated form DNA topoisomerase (ATP-hydrolysing) Treatment resistance Enzyme ovarian cancer Enzyme inhibitor Liposome Topoisomerase II inhibitor Malignant tumor Long term Female genital diseases Abdomen Case study Ovarian diseases Vascular endothelium growth factor Treatment Anthracyclins Hyperthermia Bibliographic review Cancer
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!